Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Protein links sleep and sickness

Feb. 4, 2019

Lacosamide shows promise in patients with Nav1.7-related small fiber neuropathy

Feb. 1, 2019

Metrion Biosciences and LifeArc to collaborate on ion channel drug discovery project

Feb. 1, 2019

Ohio State University, Brigham and Women's Hospital patent SLC1A2 activators

Feb. 1, 2019

New 5-HT-2A antagonists idenified at Tonix Pharmaceuticals

Feb. 1, 2019

Vanderbilt University describes muscarinic acetylcholine M4 receptor antagonists

Feb. 1, 2019

5AR targeting disrupts D1R-D3R heteromer formation and protects from dyskinesia in Parkinson's model

Jan. 31, 2019

Phase II trial explores use of oral factor XIa inhibitor BMS-986177 for secondary stroke prevention

Jan. 31, 2019

Vertex Pharmaceuticals patents sodium channel protein type 10 subunit alpha blockers

Jan. 31, 2019

FDA issues complete response letter for Sunovion's apomorphine sublingual film

Jan. 31, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...